USD 0.04
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 6.2 Million USD | -22.06% |
2022 | 7.95 Million USD | 12.96% |
2021 | 7.04 Million USD | 429.43% |
2020 | 1.33 Million USD | -16.97% |
2019 | 1.6 Million USD | 2.69% |
2018 | 1.56 Million USD | 42.43% |
2017 | 1.09 Million USD | 0.0% |
2015 | 1.05 Million USD | 2.05% |
2014 | 1.03 Million USD | 101569.92% |
2013 | 1016.16 USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 6.58 Million USD | 4.54% |
2024 Q1 | 6.29 Million USD | 1.57% |
2023 Q4 | 6.2 Million USD | 328.69% |
2023 Q3 | 1.44 Million USD | -76.15% |
2023 Q2 | 6.06 Million USD | 0.96% |
2023 Q1 | 6 Million USD | -24.5% |
2023 FY | 6.2 Million USD | -22.06% |
2022 Q3 | 203.23 Million USD | 2680.1% |
2022 FY | 7.95 Million USD | 12.96% |
2022 Q4 | 7.95 Million USD | -96.09% |
2022 Q2 | 7.31 Million USD | 1.33% |
2022 Q1 | 7.21 Million USD | 0.0% |
2021 FY | 7.04 Million USD | 429.43% |
2021 Q3 | 1.71 Million USD | 6.93% |
2021 Q2 | 1.6 Million USD | 0.0% |
2020 Q2 | 1.61 Million USD | 0.57% |
2020 Q1 | 1.6 Million USD | 0.0% |
2020 Q3 | 65 Thousand USD | -95.97% |
2020 FY | 1.33 Million USD | -16.97% |
2019 FY | 1.6 Million USD | 2.69% |
2018 Q1 | 1.09 Million USD | 0.0% |
2018 FY | 1.56 Million USD | 42.43% |
2017 FY | 1.09 Million USD | 0.0% |
2015 FY | 1.05 Million USD | 2.05% |
2014 FY | 1.03 Million USD | 101569.92% |
2013 FY | 1016.16 USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.24 Million USD | -176.816% |
Arrayit Corporation | 1.07 Million USD | -475.114% |
Atlantic International Corp. | 2.93 Million USD | -111.592% |
Biocept, Inc. | 12.1 Million USD | 48.793% |
Bioqual, Inc. | 3.58 Million USD | -72.866% |
CardioGenics Holdings Inc | 72.61 Thousand USD | -8439.242% |
DermTech, Inc. | 54.39 Million USD | 88.6% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 98.686% |
HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -28.274% |
iMD Companies, Inc. | 1.12 Million USD | -453.559% |
IDenta Corp. | 789.14 Thousand USD | -685.746% |
Interpace Biosciences, Inc. | 11.19 Million USD | 44.597% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 43.84 Thousand USD | -14042.285% |
Lumos Diagnostics Holdings Limited | 8.04 Million USD | 22.924% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 3.82 Million USD | -62.072% |
NovelStem International Corp. | 3.57 Million USD | -73.465% |
Optigenex Inc. | 8.94 Million USD | 30.647% |
PharmChem, Inc. | 77.35 Thousand USD | -7916.089% |
Proteome Sciences plc | 17.15 Million USD | 63.852% |
Response Genetics, Inc | 6.37 Million USD | 2.704% |
Rennova Health, Inc. | 15.32 Million USD | 59.55% |
RushNet, Inc. | 4.82 Million USD | -28.562% |
ScreenPro Security Inc. | 207.03 Thousand USD | -2895.008% |
StageZero Life Sciences Ltd. | 1.8 Million USD | -244.467% |
Todos Medical Ltd. | 38.34 Million USD | 83.83% |